Find clinical trials for Multiple Sclerosis (MS) in Berlin, BE
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Sclerosis (MS) trials near Berlin, BE, DEU:
Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis...
Phase 3
Berlin, Germany and 72 other locations
This study will evaluate the safety, tolerability, and descriptive efficacy of BIIB017 in pediatric participants with relapsing-remitting multiple...
Phase 3
Berlin, Germany and 65 other locations
study will compare ofatumumab vs. European approved platform first line self-administered disease modifying therapy (DMT) in newly diagnosed MS...
Phase 3
Berlin, Germany and 49 other locations
Open-label study to evaluate the effectiveness of treatment with ofatumumab in subjects transitioning from any fumarate-based RMS approved therapy or...
Phase 3
Potsdam, Germany and 122 other locations
and female participants aged 18 to 60 years with relapsing-remitting multiple sclerosis (RRMS), secondary progressive multiple...
Phase 2
Berlin, Germany and 40 other locations
The primary objective of this study is to determine the safety and tolerability of multiple doses of QRL-201 in people living with ALS...
Phase 1
Berlin, Germany and 10 other locations
This is a randomized, double blind, controlled, parallel group, multicenter study to evaluate efficacy, safety and pharmacokinetics of a higher dose...
Phase 3
Berlin, Germany and 125 other locations
relapse rate (ARR) in participants with relapsing forms of MSSecondary Objective:To assess efficacy of SAR442168 compared to teriflunomide (...
Phase 3
Berlin, Germany and 185 other locations
A study to evaluate the efficacy and safety of fenebrutinib on disability progression in adult participants with Primary Progressive Multiple...
Phase 3
Berlin, Germany and 192 other locations
A study to evaluate the efficacy and safety of fenebrutinib on disability progression and relapse rate in adult participants with RMS. Eligible parti...
Phase 3
Berlin, Germany and 168 other locations
Clinical trials
Research sites
Resources
Legal